eli lilly cipla - Search News

Cipla, Eli Lilly and India

· 1d · on MSN

Eli Lilly allows Cipla to sell weight loss drug under new brand in India

Eli Lilly signed an agreement with Cipla , allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday.

Continue reading

Cipla shares fall 3% after Eli Lilly deal to market weight-loss drug in India: Here's what analysts say

Indian pharma giant Cipla inks deal to sell Eli Lilly’s weight-loss drug under a different brand name: Why is this significant?

21h

Nuvama retains 'Hold' on Cipla, raises target after Eli Lilly diabetes deal

Cipla enters obesity and diabetes drug market with Eli Lilly's tirzepatide 'Yurpeak'; Nuvama retains 'Hold' on Cipla stock, ...

1d

Newsbreak Confirmed: What to make of Cipla's Yurpeak pact with Eli Lilly? Nuvama raises target by Rs 74

Eli Lilly's launch of Mounjaro in India in March 2025 was the first step of Tirzepatide in the country. In June 2025, the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results